Healthcare News and Research

Latest Healthcare News and Research

U.S. approval of Nexavar (sorafenib) for inoperable liver cancer

The U.S. Food and Drug Administration has approved Nexavar (sorafenib) for use in patients with a form of liver cancer known as hepatocellular carcinoma, when the cancer is inoperable.

19 Nov 2007

Combining medications often best strategy to battle rheumatoid arthritis

For patients with rheumatoid arthritis, combining one well-known, lower-cost synthetic drug with one of six biologic medications often works best to reduce joint swelling or tenderness, according to a new report by researchers at the RTI International-University of North Carolina at Chapel Hill Evidence-based Practice Center, which is sponsored by the Agency for Healthcare Research and Quality.

19 Nov 2007

Subcutaneous administration of an antiemetic for treating vomiting caused by chemotherapy

The subcutaneous administration of granisetron, an antiemetic pharmaceutical drug (suitable for control of vomiting), achieves similar blood concentrations to those administered intravenously.

19 Nov 2007

Some drug studies more likely to have favorable conclusions

Previous work has shown that, when a drug study was funded by the company that made that drug, the results might be biased in favour of that drug because the methods or analyses were manipulated.

19 Nov 2007

JRRD releases single-topic issue on traumatic brain injury and polytrauma

The Journal of Rehabilitation Research and Development (JRRD) today released a single-topic issue on traumatic brain injury (TBI) and polytrauma.

19 Nov 2007

High cost of pain in Australia

For the first time, a dollar value has been attached to the high cost of pain in Australia in an MBF Foundation funded study that reveals a massive annual cost of $34.3 billion -- nearly $11,000 for each of the estimated 3.2 million people grappling with pain.

19 Nov 2007

Weight-loss drug doubles the risk of depression and anxiety

A weight loss pill which was initially hailed as some kind of wonder drug is now thought to more than double the risk of depression, anxiety and suicidal thoughts.

19 Nov 2007

People with schizophrenia are more likely to suffer from ruptured appendix

People with mental illness suffer more than just psychological problems. People with schizophrenia are more likely to suffer from ruptured appendix than others, according to research published in the online open access journal, BMC Public Health.

16 Nov 2007

Three quarters of U.S. physicians and nurses recommend dietary supplements to their patients

The study also shows that an almost equal number - 72 percent of physicians and 89 percent of nurses - personally use vitamin, mineral, herbal and other supplements either regularly, occasionally or seasonally, which is a higher percentage than the 68 percent of adults who report they take nutritional or dietary supplements.

16 Nov 2007

Lessons learned from Turkey's 2006 bird flu outbreak

Rapid responses by Turkey's health authorities and key health personnel were critical in bringing the 2006 bird flu outbreak under control, according to research published in the online open access journal, BMC Public Health.

16 Nov 2007

From successful aging to severe dementia

A recently published special issue of the Journal of Alzheimer's Disease contains the contributions from experts in the field of aging, dementia and Alzheimer's disease, who attended the "Fourth Annual Meeting on Brain aging and Dementia - From successful aging to severe dementia”, Held in Perugia in October 2006 under the auspices of the Italian Psychogeriatric Association, a member of the International Psychogeriatric Association, the meeting celebrates the centenary of Alzheimer's first description of the disease.

16 Nov 2007

GlaxoSmithKline implements changes to the US product label for Avandia

GlaxoSmithKline announced today that it is implementing changes to the US product label for Avandia(R) (rosiglitazone maleate), based on an extensive and thorough review by the FDA of myocardial ischemia data on Avandia, the most widely studied oral anti-diabetic medicine available.

15 Nov 2007

Breakthrough innovation for high sensitivity TB and Malaria diagnostics

At this year's 39th World Forum for Medicine in Dusseldorf (MEDICA, November 14-17), Partec, a globally leading developer, manufacturer and provider of dedicated diagnostic solutions in the response to HIV/AIDS, Tuberculosis and Malaria is presenting a breakthrough innovation for high sensitivity TB and Malaria diagnostics in low- and middle-income countries.

15 Nov 2007

Medics worry about ethnic sensitivity

Health professionals worry that a lack of knowledge about different cultures may lead to them being seen as insensitive or inappropriate to patients from different ethnic backgrounds - according to research published today.

14 Nov 2007

EDMA calls for empowering people with diabetes

Type 2 diabetes and its complications are frequently diagnosed too late and the complications are often detected only at the time of diagnosis, concludes the European Parliament in its 2006 Written Declaration on Diabetes.

14 Nov 2007

UK hospitals short changing women with heart failure

Women with heart failure are less likely than men to receive recommended investigations and treatment, when admitted to hospital as an emergency, reveals an extensive UK survey, published ahead of print in the journal Heart.

14 Nov 2007

Most seniors with diabetes have at least one other major chronic medical condition

As if diabetes weren't enough to handle, a new study shows that 92 percent of older people with the disease have at least one other major chronic medical condition - and that nearly half have three or more major diseases besides their diabetes.

14 Nov 2007

Dealing with ethnic diversity in healthcare

Guidelines and training for doctors have tried to address the problems they face when dealing with patients who come from cultures and ethnic groups different to their own.

13 Nov 2007

FDA approves new nonprescription allergy drug Zyrtec-D

The Food and Drug Administration (FDA) has approved Zyrtec-D (cetirizine HCl 5 mg and pseudoephedrine HCl 120 mg), an allergy drug, for nonprescription use in adults and children 12 years of age and older. This drug combines an antihistamine with a nasal decongestant.

13 Nov 2007

Collaboration between Eastern and Western healthcare practitioners is needed

Recent study findings from The Cleft Palate–Craniofacial Journal stress the importance of culturally sensitive rehabilitative practices, collaboration, referrals and information sharing between Eastern and Western health care practitioners.

13 Nov 2007